Gambro: Six Month Report, January - June 2002


STOCKHOLM, Sweden, July 26, 2002 (PRIMEZONE) -- Gambro:


-- Group revenues increased 9%, good organic growth in all business areas
-- Operating earnings, EBITDA, up 5% (up 87% incl. nonrecurring 2001)
-- Operating cash flow strong at MSEK 480 (-730)

MSEK                     Q2            Curr   January-June          Curr
                                       ency                         ency
(excl  nonrecurring   2002  2001  Cha  adju    2002    2001  Chang  adju
items)                            nge  sted                      e  sted
Revenues             7,053 6,619  +7%  +10%  13,962  12,799    +9%   +9%
EBITDA(1)            1,126 1,076  +5%   +7%   2,232   2,122    +5%   +4%
EBITDA margin        16.0% 16.3%              16.0%   16.6%             
EBITDA margin (incl  16.0%  2.2%              16.0%    9.3%             
nonrecurring)
Operating cash flow    336  -300                480    -730             
Earnings per share,   0.13  0.13               0.39    0.45
SEK
Cash earnings(2) per  2.21  2.12               4.56    4.26
share, SEK

(1)       Earnings before depreciation and amortization
(2)       Net income plus depreciation and amortization

Second quarter highlights:


-- Strong revenue growth, +10% currency adjusted, in all significant 
   respects organic.

-- Gambro Healthcare revenue per treatment in the U.S. improved by USD 6
   to USD 252.

-- Continued strong development of operating cash flow due to strong 
   growth within all business areas and improved performance within
   Gambro Healthcare.

-- Cash  flow, currency effects and very few acquisitions led to
   reduced net debt.

-- EBITDA  margin for the group remained stable from the first quarter 
   this year but somewhat lower than the second quarter last year.

-- Margin improvement in Gambro Healthcare. Gambro Renal Products'
   margin was somewhat reduced from last year's high level. Gambro BCT's
   margin was significantly lower in line with the strategy to widen its
   business scope, including expansion of PET spending.

"We see the momentum in our services business; our action program has started to pay off in a market without external positive contribution," said Soren Mellstig, Gambro president and CEO. "The product and business shift in our product business areas affected our margins in the quarter."

For further information please contact:


Lars Granlof, Senior Vice President, CFO, tel. +46-8-613 65 00,
+46 70 513 65 48
Janette Jennische, Vice President, Corporate Communications,
tel. +46 8 613 65 00, +46 70 212 50 53
Pia Irell, Director, Investor Relations, tel. +46 8 613 65 00,
+46 70 513 65 91
Kevin Smith, President, Gambro Inc., Investor Relations U.S.,
tel. +1 303 231 4750

Gambro's financial information is also available on the Internet: www.gambro.com

The company will host a conference call and web cast to present its second quarter results today at 16:00 Central European time. Teleconference callers should dial +44 (0)20 8781 0577 (if calling from Europe) or +1 303 713 7929 (if calling from the US). Regarding the web cast, please find all related information on Gambro's web site: www.gambro.com/investors/.

Next report:

Nine-month report: October 25, 2002

This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download:


www.waymaker.net/bitonline/2002/07/26/20020726BIT00030/wkr0001.doc
The full report

www.waymaker.net/bitonline/2002/07/26/20020726BIT00030/wkr0002.pdf
The full report